Patents by Inventor Kavian Shahi

Kavian Shahi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ankle and foot bone growth compositions and methods
    Patent number: 9155629
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: October 13, 2015
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Bone Growth Compositions and Methods
    Publication number: 20120276204
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Application
    Filed: November 29, 2011
    Publication date: November 1, 2012
    Applicant: Neuropro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Bone growth compositions and methods
    Patent number: 8088402
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: January 3, 2012
    Assignee: Neuropro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Bone Growth Compositions and Methods
    Publication number: 20060233853
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Application
    Filed: June 2, 2006
    Publication date: October 19, 2006
    Inventors: Benjamin Remington, David Bearss, Kavian Shahi
  • Bone growth compositions and methods
    Patent number: 7108862
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: September 19, 2006
    Assignee: Neuropro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Spinal fusion using an HMG-CoA reductase inhibitor
    Patent number: 7041309
    Abstract: An improved technique for spinal fusion including administration of an HMG-CoA reductase inhibitor to the fusion site. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a noncompressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: May 9, 2006
    Assignee: NeuroPro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Bone growth compositions and methods
    Publication number: 20040006125
    Abstract: The present invention provides an improved technique for spinal fusion involving the administration of an HMG-CoA reductase inhibitor to a fusion. The HMG-CoA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a non-compressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Application
    Filed: June 11, 2003
    Publication date: January 8, 2004
    Applicant: NeuroPro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Apparatus and methods for detecting cerebrospinal fluid
    Publication number: 20040002168
    Abstract: Antibodies, apparatus and methods of detecting and diagnosing cerebrospinal fluid and conditions associated therewith are disclosed. In particular embodiments, CSF specific proteins are detected with antibodies in a strip test.
    Type: Application
    Filed: June 11, 2003
    Publication date: January 1, 2004
    Applicant: NeuroPro Technologies, Inc.
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi
  • Spinal fusion using an HMG-CoA reductase inhibitor
    Publication number: 20030232065
    Abstract: An improved technique for spinal fusion including administration of an HMG-CoA reductase inhibitor to the fusion site. The HMG-COA reductase inhibitor is preferably delivered to the site by a carrier. More preferably, the HMG-CoA reductase inhibitor is delivered to the site by a noncompressible delivery vehicle. The invention is suitable for promoting non-anatomic or heterotopic bone growth between any bony surfaces where bone growth is desired but does not naturally occur.
    Type: Application
    Filed: October 28, 2002
    Publication date: December 18, 2003
    Inventors: Benjamin J. Remington, David J. Bearss, Kavian Shahi